Atlas Trials

A Phase III Study of KHN939 in Chinese Patients With Moderate-to-Severe Active Thyroid Eye Disease

Clinical trial NCT07720635 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07720635
Sponsor
Beijing Kanghong Biological Medicine Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Thyroid Eye Disease
Start date
2026-08-01
Primary completion
2027-04-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.